The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $4,384.91 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 100 units of the pharmaceutical product XTAMPZA ER 36 MG CAPSULE. This order is being fulfilled under an existing indefinite delivery contract (IDC) issued by DLA to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to support Department of Defense military treatment programs and facilities worldwide. The IDC, which does not have any set-aside designations, has a total potential value of $999,999,999.00 and is active through December 31, 2025. AmerisourceBergen Drug Corp is the sole prime contractor on this IDC.
Generated 6/6/24, 10:11 AM